TP53 and glioblastoma: The key genetic alterations characterized in GBM include TERT promoter mutation, PTEN tumor suppressor gene deletion, high-level gene amplification of proto-oncogene EGFR, ATRX mutation, and TP53 mutation [4,17,21].